Investor profile
The Fink Family Office has backed 4 European tech companies across 5 funding rounds between 2022 and 2025, joining rounds totalling €8.8M. Most active in Healthtech and Robotics. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| EnsiliTech | UK | 2 | €6.6M |
| QV Bioelectronics | UK | 1 | €2.3M |
| CheMastery | UK | 1 | €0 |
| MitoRx Therapeutics | UK | 1 | €0 |
| Company | Stage | Amount | Date |
|---|---|---|---|
| EnsiliTech | Seed | €5.2M | 2025-08 |
| QV Bioelectronics | Seed | €2.3M | 2023-01 |
| EnsiliTech | Pre-Seed | €1.4M | 2023-01 |